Translating Metabolic Reprogramming into New Targets for Kidney Cancer
Kidney Cancer · 2017
DOI: 10.3233/kca-170014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Cancer, 2017. Verfasst von Omran Abu Aboud und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of California Davis, Davis, CA, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
In the age of bioinformatics and with the advent of high-powered computation over the past decade or so the landscape of biomedical research has become radically altered. Whereas a generation ago, investigators would study their “favorite” protein or gene and exhaustively catalog the role of this compound in their disease of interest, the appearance of omics has changed the face of medicine such that much of the cutting edge (and fundable!) medical research now evaluates the biology of the disease nearly in its entirety. Couple this with the realization that kidney cancer is a “metabolic disease” due to its multiple derangements in biochemical pathways [ 1 , 2 ], and clear cell renal cell carcinoma (ccRCC) becomes ripe for data mining using multiple omics approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, University of California Davis, Davis, CA, USA.
- Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
- Medical Service, VA Northern California Health Care System, Sacramento, CA, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Abu Aboud, O., & Weiss, R. H. (2017). Translating Metabolic Reprogramming into New Targets for Kidney Cancer. Kidney Cancer. https://doi.org/10.3233/kca-170014
Vancouver
Abu Aboud O, Weiss RH. Translating Metabolic Reprogramming into New Targets for Kidney Cancer. Kidney Cancer. 2017. doi:10.3233/kca-170014
BibTeX
@article{AbuAboud2017,
author = {Abu Aboud, Omran and Weiss, Robert H},
title = {Translating Metabolic Reprogramming into New Targets for Kidney Cancer},
journal = {Kidney Cancer},
year = {2017},
doi = {10.3233/kca-170014}
}
EUVIMED